Nexalis Therapeutics Archives | Cannabiz

Nexalis trials still on hold as directors ponder revision of clinical program

by Steve Jones August 1, 2026August 1, 2026

ASX-listed Nexalis Therapeutics is still scrambling to secure funds for its cannabinoid clinical trials following the […]

Replacement funding falls through as Nexalis studies remain suspended

by Adam Sheldon July 6, 2026July 9, 2026

Nexalis suspends trial projects after funding partner withdraws support

by Steve Jones June 1, 2026June 1, 2026

News in brief: Judgment reserved in CDA Clinics QLD legal case; Nexalis completes Phase 1 IRX-616a dosing

by Adam Sheldon May 18, 2026June 8, 2026

News in brief: Nexalis advances IRX-616a and IRX-211 programs; Vitura heralds Doctors on Demand growth; Elixinol improves cash flow

by Adam Sheldon April 20, 2026June 11, 2026

Nexalis outlines 2026 plan as IRX shares jump 35%

by Adam Sheldon February 17, 2026February 19, 2026